Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Celyad SA (CLYYF)
OTHER OTC:CLYYF
Holding CLYYF?
Track your performance easily
CLYYF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.25 - $0.68
Previous Close$0.68
Volume2.42K
Average Volume (3M)2.42K
Market Cap
$29.14M
Enterprise Value$16.61M
Total Cash (Recent Filing)€12.40M
Total Debt (Recent Filing)€255.00K
Price to Earnings (P/E)―
Beta-0.29
Next Earnings
Apr 02, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.26
Shares Outstanding22,593,956
10 Day Avg. Volume242
30 Day Avg. Volume2,420
Standard Deviation0.35
R-Squared0.04
Alpha-0.08
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CLYYF FAQ
What was Celyad SA’s price range in the past 12 months?
Celyad SA lowest stock price was $0.24 and its highest was $0.68 in the past 12 months.
What is Celyad SA’s market cap?
Currently, no data Available
When is Celyad SA’s upcoming earnings report date?
Celyad SA’s upcoming earnings report date is Apr 02, 2025 which is in 86 days.
How were Celyad SA’s earnings last quarter?
Currently, no data Available
Is Celyad SA overvalued?
According to Wall Street analysts Celyad SA’s price is currently Overvalued.
Does Celyad SA pay dividends?
Celyad SA does not currently pay dividends.
What is Celyad SA’s EPS estimate?
Celyad SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Celyad SA have?
Celyad SA has 41,428,574 shares outstanding.
What happened to Celyad SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Celyad SA?
Currently, no hedge funds are holding shares in CLYYF
---
Company Description
Celyad SA
Celyad SA is a clinical-stage biopharmaceutical company, which engages in the development of cell-based therapies for the treatment of cancer. It operates through the following segments: Cardiology, Immuno-oncology, and Corporate. The Cardiology segment includes the company's Cardiopoiesis, Corquest, and C-Cathez platforms. The Immuno-oncology segment consists of all assets developed based on the CAR-T cell platform. The company was founded by Michel Lussier, William Wijns, and Christian Homsy on July 24, 2007 and is headquartered in Mont-Saint-Guibert, Belgium.
---
Technical Analysis
---